The inaugural Seminar Series will deliver an over-arching view of the key health economic, intellectual property, regulatory, clinical, manufacturing, analytical and investment considerations for developers to balance the requirements of all stakeholders, enabling both the immediate and future development needs of their therapy to be met in the pathway to commercialisation
Day 1 – Monday 12 February 08:30-17:00
Day 2 – Tuesday 13 February 08:30-17:00
The Alliance for Regenerative Medicine Cell & Gene Therapies State of the Industry Briefing is a cell and gene therapies-focused annual event taking place during JP Morgan week.
Connecting cell and gene therapy leaders to drive manufacturing and commercialisation through direct access to innovative discovery, product development and regulatory know-how.